Pcr Technologies

Polymerase Chain Reaction (PCR) Market (Products: Instruments, and Reagents & Consumables; End-users: Pharmaceutical and Biotech Industries, Clinical Diagnostics Laboratories, Academics and Universities; and Applications: Clinical Diagnostics, Life Sciences and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • Rep Id : TMRGL830
  • Published On : Feb 2015
  • No. of Pages : 114
  • Category : Healthcare

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
              1.3.1.1 Secondary Research
              1.3.1.2 Primary Research
      1.3.2 Assumptions
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global PCR Market (2013 & 2020)
2.2 Global PCR Market Revenue, by Products, 2012 - 2020 (USD Million)
2.3 Comparative Analysis: Global PCR Market Revenue, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Global PCR, Market Overview
3.1 Overview
3.2 Polymerase Chain Reaction Techniques
      3.2.1 Conventional PCR
      3.2.2 Real time/Quantitative PCR
      3.2.3 Reverse transcription PCR (RT-PCR)
      3.2.4 Digital PCR
      3.2.5 Hot Start PCR
      3.2.6 Multiplex PCR
3.3 Market Dynamics
      3.3.1 Market Drivers
              3.3.1.1 Rising demand for advanced molecular diagnostics to accurately diagnose life-threatening diseases
              3.3.1.2 Increase in private and public funding has promoted PCR-based drug discovery, genomics, and personalized medicine
              3.3.1.3 Growing demand for automated equipment  and multifaceted analytical strategies is expected to increase the use of PCR
              3.3.1.4 Development of new tests, increasing awareness of molecular diagnostics to boost the market
      3.3.2 Market Restraints
              3.3.2.1 High cost associated with PCR diagnostic kits and assays may impact the market growth
              3.3.2.2 Lack of skilled labor and inefficient data analysis tools 
              3.3.2.3  Increasing competition from newer technologies such as NGS is likely to hamper the growth of PCR instruments
      3.3.3 Market Opportunities
              3.3.3.1 Targeted therapy and personalized medicine to spur the PCR industry
              3.3.3.2 Focus on extensive research and development to expand existing PCR applications
3.4 Porter’s Five Forces Analysis for the Global PCR Market
      3.4.1 Bargaining power of suppliers
      3.4.2 Bargaining power of buyers
      3.4.3 Threat of substitutes
      3.4.4 Threat of new entrants
      3.4.5 Competitive rivalry
3.5 Market Attractiveness Analysis: Global PCR Market, by Geography
3.6 Competitive Landscape
      3.6.1 Market Share Analysis: Global PCR Market, 2013 (Value %)
3.7 Event Impact Analysis
 
Chapter 4 Global Polymerase Chain Reaction Market Revenue, by Products, 2012 – 2020 (USD Million)
4.1 Overview
      4.1.1 Global PCR Market Revenue, by Products, 2012 - 2020 (USD Million)
      4.1.2 Comparative Analysis: Global PCR Market Revenue, by Products, 2013 & 2020 (Value %)
4.2 Instruments
      4.2.1 Global PCR Instruments Market Revenue, by Type, 2012 - 2020 (USD Million)
      4.2.2 Standard PCR Systems
              4.2.2.1 Global Standard PCR Market Revenue, 2012 – 2020 (USD Million)
      4.2.3 Real Time PCR (qPCR) Systems
              4.2.3.1 Global Real Time PCR (qPCR) Market Revenue, 2012 – 2020 (USD Million)
      4.2.4 Digital PCR (dPCR) Systems
              4.2.4.1 Global Digital PCR Market Revenue, 2012 – 2020 (USD Million)
4.3 Reagents and Consumables
      4.3.1 Global Reagents and Consumables Systems Market Revenue, 2012 – 2020 (USD Million)
              4.3.1.1 PCR Enzymes, by Key Players 
 
Chapter 5 Global Polymerase Chain Reaction Market Revenue, by End-user, 2012 – 2020 (USD Million)
5.1 Introduction
      5.1.1 Global PCR Market Revenue, by End-user, 2012 – 2020 (USD Million)
      5.1.2 Comparative Analysis: Global PCR Market, by End-users, 2013 & 2020 (Value %)
5.2 Pharmaceuticals and Biotechnology Industries
      5.2.1 Global Pharmaceutical and Biotechnology Companies Market Revenue, 2012 – 2020 (USD Million)
5.3 Clinical Diagnostics Laboratories and Hospitals
      5.3.1 Global Clinical Diagnostics Labs and Hospitals Market Revenue, 2012 – 2020 (USD Million)
5.4 Academic and Public Research Organizations
      5.4.1 Global Academic and Public Research Organizations Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 6 Global PCR Market Revenue, by Applications, 2012 - 2020 (USD Million)
6.1 Introduction
      6.1.1 Global PCR Market Revenue, by Applications, 2012 - 2020 (USD Million)
6.2 Clinical Diagnostics
      6.2.1 Comparative Analysis: Global PCR Clinical Diagnostics Market Share, by Infectious and Non-Infectious Diseases, 2013
      6.2.2 Global Clinical Diagnostics Market Revenue, 2012 – 2020 (USD Million)
6.3 Life Sciences
      6.3.1 Global Life Sciences Market Revenue, 2012 – 2020 (USD Million)
6.4 Others
      6.4.1 Global Others Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 7 Global PCR Market Revenue, by Geography, 2012-2020 (USD Million)
7.1 Introduction
      7.1.1 Global PCR Market Revenue, by Geography, 2012 - 2020 (USD Million)
7.2 North America
      7.2.1 North America PCR Market Revenue, 2012 – 2020 (USD Million)
7.3 Europe
      7.3.1 Europe PCR Market Revenue, 2012 – 2020 (USD Million)
7.4 Asia Pacific
      7.4.1 Asia Pacific PCR Market Revenue, 2012 – 2020 (USD Million)
7.5 Rest of the World
      7.5.1 Rest of the World PCR Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 8 Recommendations
8.1 Strategies for Success
      8.1.1 Focus on Research and Development
      8.1.2 Mergers and Acquisitions to Propel the Market Growth
      8.1.3 Collaboration: A Key to Innovation
 
Chapter 9 Company Profiles
9.1 Abbott Laboratories
      9.1.1 Company Overview
      9.1.2 Product Portfolio
      9.1.3 Financial Overview
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Affymetrix, Inc.
      9.2.1 Company Overview
      9.2.2 Product Portfolio
      9.2.3 Financial Overview
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Agilent Technologies, Inc.
      9.3.1 Company Overview
      9.3.2 Product Portfolio
      9.3.3 Financial Overview
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Becton, Dickinson & Company
      9.4.1 Company Overview
      9.4.2 Product Portfolio
      9.4.3 Financial Overview
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Beckman Coulter, Inc
      9.5.1 Company Overview
      9.5.2 Product Portfolio
      9.5.3 Financial Overview
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Bio-Rad Laboratories, Inc.
      9.6.1 Company Overview
      9.6.2 Product Portfolio
      9.6.3 Financial Overview
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 GE Healthcare
      9.7.1 Company Overview
      9.7.2 Product Portfolio
      9.7.3 Financial Overview
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 QIAGEN
      9.8.1 Company Overview
      9.8.2 Product Portfolio
      9.8.3 Financial Overview
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Sigma-Aldrich Co. LLC.
      9.9.1 Company Overview
      9.9.2 Product Portfolio
      9.9.3 Financial Overview
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Thermo Fisher Scientific, Inc.
      9.10.1 Company Overview
      9.10.2 Product Portfolio
      9.10.3 Financial Overview
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 F. Hoffmann-La Roche Ltd.
      9.11.1 Company Overview
      9.11.2 Product Portfolio
      9.11.3 Financial Overview
      9.11.4 Business Strategies
      9.11.5 Recent Developments

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global PCR Market (2013 & 2020)
TABLE 3 Event Impact Analysis : Global PCR Market
TABLE 4 Global PCR Market Revenue, by Products, 2012 - 2020 (USD Million)
TABLE 5 Global PCR Instruments Market Revenue, by Type, 2012 - 2020 (USD Million)
TABLE 6 Standard PCR Systems, by Key Players
TABLE 7 Real Time PCR Systems, by Key Players
TABLE 8 Digital PCR Systems, by Key Players
TABLE 9 PCR Enzymes, by Key Players
TABLE 10 Global PCR  Market Revenue, by End-user, 2012 – 2020 (USD Million)
TABLE 11 FDA-approved PCR-based (nucleic acid) Tests
TABLE 12 FDA-approved PCR-based Companion Diagnostic Devices
TABLE 13 Global PCR Market Revenue, by Applications, 2012 - 2020 (USD Million)
TABLE 14 Global PCR Market Revenue, by Geography, 2012 - 2020 (USD Million)
TABLE 15 North America PCR Market Revenue, by Products, 2012 - 2020 (USD Million)
TABLE 16 Europe PCR Market Revenue, by Products, 2012 - 2020 (USD Million)
TABLE 17 Asia Pacific PCR Market Revenue, by Products, 2012 - 2020 (USD Million)
TABLE 18 RoW PCR Market Revenue, by Products, 2012 - 2020 (USD Million)

List of Figures
 
FIG. 1 Market Segmentation: Global PCR Market
FIG. 2 Comparative Analysis: Global PCR Market Revenue, by Geography, 2013 &2020 (Value %)
FIG. 3 Porter’s Five Forces Analysis: Global PCR Market
FIG. 4 Market Attractiveness Analysis: Global PCR Market, by Geography, 2013
FIG. 5 Market Share Analysis: Global PCR Market, 2013
FIG. 6 Comparative Analysis: Global PCR Market Revenue, by Products, 2013 & 2020 (Value %)
FIG. 7 Global Standard PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 8 Global Real Time PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 9 Global Digital PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Reagents and Consumables Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Comparative Analysis: Global PCR Market, by End-users, 2013 & 2020 (Value %)
FIG. 12 Global Pharmaceutical and Biotechnology Companies Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Clinical Diagnostics Labs and Hospitals Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Academic and Research Organizations Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Comparative Analysis: Global PCR Clinical Diagnostics Market Share, by Infectious and Non-Infectious Diseases, 2013
FIG. 16 Global Clinical Diagnostics Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Global Life Sciences Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Global Others Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 North America PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Europe PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Asia Pacific PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Rest of the World PCR Market Revenue, 2012 – 2020 (USD Million)
FIG. 23 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 Affymetrix, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Agilent Technologies, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Becton, Dickinson and Company: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 Bio-Rad Laboratories, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 QIAGEN: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 30 Sigma-Aldrich Co. LLC.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 31 Thermo Fisher Scientific Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 32 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 – 2013 (USD Million)